Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitors

The design and synthesis of a novel class of amino(methyl) pyrrolidine-based sulfonamides as potent and selective FXa inhibitors is reported. The amino(methyl) pyrrolidine scaffolds were designed based on the proposed bioisosterism to the piperazine core in known FXa inhibitors. The SAR study led to...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 17; no. 21; pp. 5952 - 5958
Main Authors Shi, Yan, Sitkoff, Doree, Zhang, Jing, Han, Wei, Hu, Zilun, Stein, Philip D., Wang, Ying, Kennedy, Lawrence J., O’Connor, Stephen P., Ahmad, Saleem, Liu, Eddie C.-K., Seiler, Steve M., Lam, Patrick Y.S., Robl, Jeffrey A., Macor, John E., Atwal, Karnail S., Zahler, Robert
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 01.11.2007
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The design and synthesis of a novel class of amino(methyl) pyrrolidine-based sulfonamides as potent and selective FXa inhibitors is reported. The amino(methyl) pyrrolidine scaffolds were designed based on the proposed bioisosterism to the piperazine core in known FXa inhibitors. The SAR study led to compound 15 as the most potent FXa inhibitor in this series, with an IC 50 of 5.5 nM and PT EC 2x of 1.7 μM. The proposed binding models show that the pyrrolidine cores are in van der Waals contact with the enzyme surface, and the flexibility of amino(methyl) pyrrolidines allows the two nitrogen atoms to anchor both the P1 and P4 groups to fit similarly in the S1 and S4 pockets.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2007.07.063